Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02234700
Other study ID # TASMC-14-AA-0071-CTIL
Secondary ID
Status Recruiting
Phase N/A
First received August 26, 2014
Last updated September 8, 2014
Start date August 2014
Est. completion date February 2015

Study information

Verified date September 2014
Source Western Galilee Hospital-Nahariya
Contact abdelhakim Ayub, MD
Phone 0502999110
Email abedayub@gmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational [Patient Registry]

Clinical Trial Summary

Comparison between patients with nasolacrimal duct obstruction and healthy patients and the influence of their bacterial flora on the corneal epithelium.


Description:

Any patient with nasolacrimal duct obstruction above the age of 18 Comparing changes in their bacterial ocular flora to healthy patients without obstruction and above 18 years of age


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older, nasolacrimal duct obstruction

Exclusion Criteria:

- younger then 18 years of age

- ocular infections

- patients after repair of lacrimal duct surgery

- systemic active diseases

- patients taking medication that are know to influence bacterial flora of the eye

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Acquired Nasolacrimal Duct Obstruction

Locations

Country Name City State
Israel Western Galileeh Hospital Naharya

Sponsors (1)

Lead Sponsor Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary the change of ocular normal flora in patients with nasolacrimal duct obstruction as a comparison to general population. as the literature suggests most of the ocular flora is composed of Staphylococcus and Haemophilus, any change in these composition will be considered abnormal. 6 month No